Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
After receiving the vaccination, the patient lost control and feeling of his left arm and hand. That injury was identified as Parsonage-Turner syndrome in his left upper extremity; This spontaneous case was reported by an attorney and describes the occurrence of NEURALGIC AMYOTROPHY (After receiving the vaccination, the patient lost control and feeling of his left arm and hand. That injury was identified as Parsonage-Turner syndrome in his left upper extremity) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEURALGIC AMYOTROPHY (After receiving the vaccination, the patient lost control and feeling of his left arm and hand. That injury was identified as Parsonage-Turner syndrome in his left upper extremity) (seriousness criterion disability). At the time of the report, NEURALGIC AMYOTROPHY (After receiving the vaccination, the patient lost control and feeling of his left arm and hand. That injury was identified as Parsonage-Turner syndrome in his left upper extremity) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. The patient was an employee since 09-Jan-1989. It was reported that, after receiving the vaccination, the patient lost control and feeling of his left arm and hand. That injury was identified as Parsonage-Turner syndrome in his left upper extremity, that was a brachial plexus injury associated with the COVID-19 vaccination. The patient was an individual with a qualified disability and was not allowed to return to work and ultimately his employment was terminated on 22-Jan-2024. No treatment information was provided.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.